CVE-2025-0416: Valmet Valmet DNA

Valmet DNA Local privilege escalation through insecure DCOM configuration

CVSS 8.9 HighEPSS 0.0021 · 11th percentile

Published by the CVE Program (CNA: NCSC-FI) at 1 Apr 2025, 04:05 UTC. agentprime has not analysed this yet, so whether it affects any app is not known. This CVE names a vendor and product rather than a package, so the lockfile check doesn’t match it.

Affected products, as the CNA wrote them
Vendor	Product	Versions
Valmet	Valmet DNA	affected C2007 to C2022, inclusive custom Other versions: unaffected

Identifiers

CVE-2025-0416

CNA

NCSC-FI

Weakness (CWE)

CWE-250

Not analysed yet

We haven’t published our own analysis of this CVE. If a person reviews it, this page will say what’s affected and what has to be true for it to matter.

Severity and exploitation

Score	Rating	CVSS	Vector	Source
8.9	High	4.0	CVSS:4.0/AV:A/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/S:N/AU:Y/R:U/V:D/RE:H/U:Amber	CNA (NCSC-FI)

CISA KEV Not listed.
EPSS 0.0021, the 11th percentile, on 7 Nov 2026: FIRST’s estimate of the chance of exploitation in the next 30 days.

Timeline

This record came from the full history of the CVE Program, published 1 Apr 2025. New records show when each source confirmed them.

Sources

References from the CNA

www.valmet.com/about-us/about/research-and-development/vulnerabilityadvisories/cve-2025-0416/

Facts on this page come from the CVE List as the CNA published them, with CVSS from the sources named above, CISA KEV and FIRST EPSS. Vendors, products and versions are shown as the CNA wrote them. We don’t reproduce the CVE’s description.